Article: Genesis Bioventures Signs Exclusive Agreement to Commercialize Mad Cow Disease Rapid Test in Pacific Rim.

NEW YORK, June 16 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has granted an exclusive license to Bio Business Development Company (BBDC) to commercialize the Rapid Prion Detection Assays in eighteen countries of the Pacific Rim. The licensed technology has been developed by Prion Developmental Laboratories (PDL), a portfolio company of GBI.

GBI has the exclusive, worldwide sales, marketing and distribution rights to commercialize the recently patented Rapid Prion Detection Assays, including rapid tests for Bovine Spongiform Encephalopathy (BSE or mad cow disease) in cattle and scrapie in sheep. With the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!